311 related articles for article (PubMed ID: 15967906)
1. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer.
Pawlik TM; Abdalla EK; Barnett CC; Ahmad SA; Cleary KR; Vauthey JN; Lee JE; Evans DB; Pisters PW
Arch Surg; 2005 Jun; 140(6):584-9; discussion 589-91. PubMed ID: 15967906
[TBL] [Abstract][Full Text] [Related]
2. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.
Capussotti L; Massucco P; Ribero D; Viganò L; Muratore A; Calgaro M
Arch Surg; 2003 Dec; 138(12):1316-22. PubMed ID: 14662531
[TBL] [Abstract][Full Text] [Related]
3. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
[TBL] [Abstract][Full Text] [Related]
4. [Lymph node resection for carcinoma of the pancreas].
Sauvanet A
J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S31-12S35. PubMed ID: 19194355
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
6. Pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma.
Kennedy EP; Yeo CJ
Surg Oncol Clin N Am; 2007 Jan; 16(1):157-76. PubMed ID: 17336242
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
[TBL] [Abstract][Full Text] [Related]
8. [Patients with non-advanced pancreatic cancer benefit from extended lymphadenectomy].
Popiela T; Kedra B; Sierzega M; Kubisz A
Zentralbl Chir; 2002 Nov; 127(11):960-4. PubMed ID: 12476369
[TBL] [Abstract][Full Text] [Related]
9. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T
J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
[TBL] [Abstract][Full Text] [Related]
10. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
Meriggi F; Gramigna P; Forni E
Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
[TBL] [Abstract][Full Text] [Related]
12. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Tanizawa Y
Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323
[TBL] [Abstract][Full Text] [Related]
13. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
14. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
Sierzega M; Popiela T; Kulig J; Nowak K
Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
Shimada K; Sakamoto Y; Sano T; Kosuge T
Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
[TBL] [Abstract][Full Text] [Related]
16. Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma.
Yoshida T; Matsumoto T; Sasaki A; Shibata K; Aramaki M; Kitano S
Am J Surg; 2004 Jun; 187(6):736-40. PubMed ID: 15191867
[TBL] [Abstract][Full Text] [Related]
17. [Benefits of extended lymphadenectomy in patients with gastric carcinoma with metastasis to second level lymph nodes. An Italian multicenter study].
Roviello F; Marrelli D; Morgagni P; De Manzoni G; Di Leo A; Vindigni C; Nastri G; Saragoni L; Tomezzoli A; Kurihara H; De Stefano A
Chir Ital; 2003; 55(4):491-8. PubMed ID: 12938593
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study.
Lygidakis NJ; Stringaris K
Hepatogastroenterology; 1996; 43(9):671-80. PubMed ID: 8799414
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of carcinoma of the head of pancreas: extended lymphadenectomy or modified en bloc resection?
Samra JS; Gananadha S; Hugh TJ
ANZ J Surg; 2008 Apr; 78(4):228-36. PubMed ID: 18366391
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of lymph node metastases in pancreatic head cancer treated with extended lymphadenectomy: not just a matter of numbers.
Massucco P; Ribero D; Sgotto E; Mellano A; Muratore A; Capussotti L
Ann Surg Oncol; 2009 Dec; 16(12):3323-32. PubMed ID: 19777195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
